Study Stopped
never started
Physical Examination-Indicated Pessary
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Cervical insufficiency, previously referred to as cervical incompetence, has classically been defined as painless dilation of the cervix in the absence of contractions or bleeding in the second trimester resulting in recurrent pregnancy losses. Painless mid-trimester cervical dilation is an uncommon finding in the general population occurring in less than 1% of pregnancies. Cerclage for the prevention pregnancy loss in cases with both prior preterm births and/or second trimester losses, as well as second trimester cervical dilatation in the index pregnancy, was first reported in the 1950's. Cerclage placement in this setting has been variably referred to as "physical exam-indicated cerclage", "rescue cerclage", and "emergency cerclage". To date, the benefits of cerclage for this indication are not entirely clear. A recent meta-analysis showed that physical exam-indicated cerclage is associated with a reduction in perinatal mortality and prolongation of pregnancy when compared to no such cerclage. Recently, several RCTs have shown that cervical pessary could decrease the incidence of PTB in several populations. Thus, the aim of our trial as noninferiority trial is to evaluate the efficacy of pessary compared to cervical cerclage in prevention of PTB in women in the setting of mid-trimester cervical dilation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Nov 2016
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 11, 2016
CompletedFirst Posted
Study publicly available on registry
November 18, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedNovember 19, 2018
November 1, 2018
1.1 years
November 11, 2016
November 15, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Neonatal survival
From delivery to 28 days
Secondary Outcomes (4)
Preterm birth
time of delivery
Latency
time of delivery
Birth weight
time of delivery
gestational age at delivery
time of delivery
Study Arms (2)
Cervical pessary
EXPERIMENTALArabin Pessary
Cervical cerclage
ACTIVE COMPARATORMcDonald Cerclage
Interventions
Eligibility Criteria
You may qualify if:
- Singleton pregnancies
- Cervical dilation between 1 to 5 cm and/or visible membranes by pelvic exam or speculum exam between at 16-23 6/7 weeks gestation
You may not qualify if:
- Pessary or cerclage already in situ
- active vaginal bleeding
- Placenta previa/accreta
- Multiple gestations
- Amniotic membranes prolapsed beyond external os into the vagina, unable to visualize cervical tissue
- Ruptured amniotic membranes at the time of diagnosis of dilated cervix
- Cervical dilation more than 5 cm
- Labor (progressing cervical dilation) or painful regular uterine contractions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gabriele Saccone
Napoli, 80129, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
November 11, 2016
First Posted
November 18, 2016
Study Start
November 1, 2016
Primary Completion
December 1, 2017
Study Completion
March 1, 2018
Last Updated
November 19, 2018
Record last verified: 2018-11